Filing Details

Accession Number:
0001209191-22-061483
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 17:23:04
Reporting Period:
2022-12-08
Accepted Time:
2022-12-15 17:23:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1879223 Juan Graham C/O Fibrogen, Inc.
409 Illinois Street
San Francisco CA 94158
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-08 5,263 $14.84 50,628 No 4 S Direct
Common Stock Disposition 2022-12-08 478 $15.47 50,150 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.